Prima on a slippery slide
What is going on inside Prima they continue on an accelerated down hill slide with no end inside and not one word from the Company to re-assure us poor loyal investors to "hang in" their.
Don't buy in to the negativity surrounding Prima, nothing has changed- we are still expecting very good OS data on Cvac either June/ July, and who knows what's in store for us as a result of the Immunotep acquisition, the sweetener that Prima has basically bet the company on- and obviously see more potential in than CVac.
For one the most respected bio tech analysts to leave his job at Bell Potter to become head of investor relations at Prima, Stuart Roberts can see what potential Prima has.
If you believe stay in there, patrience will be rewarded.